A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis

British Journal of Rheumatology

Volumn 36, Issue 2, 1997, Pages 164-169

  Littler, A J ^a   Buckley, C D ^a   Wordsworth, P ^b   Collins, I ^a   Martinson, J ^a   Simmons, D L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RandD Systems Europe Ltd   (United Kingdom)

Author keywords

Rheumatoid arthritis; Soluble E selectin; Soluble ICAM 1; Soluble ICAM 3; Soluble L selectin; Soluble P selectin; Soluble VCAM 1

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GOLD; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; L SELECTIN; METHOTREXATE; PADGEM PROTEIN; PREDNISOLONE; SALAZOSULFAPYRIDINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030794169     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.2.164     Document Type: Article

References (36)

1. Newman W, Beall LD, Carson CW et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993;150:644-54.
2. Schleiffebaum BO, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992;119:229-38.
3. Dunlop LC, Skinner MP, Bendall LJ et al. Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992;175:1147-50.
4. Goldberger A, Middleton KA, Oliver JA et al. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem 1994;269:17183-91.
5. Wellicome SM, Kapahi P, Mason JC, Lebranchu Y, Yarwood H, Haskard DO. Detection of a circulating form of vascular cell adhesion molecule-1: paired levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993;92:412-8.
6. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;33:83-4.
7. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-3.
8. del Pozo MA, Pulido R, Muñoz C el al. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism. Eur J Immunol 1994;24:2586-94.
9. Martin S, Rieckmann P, Melchers I et al. Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1. J Immunol 1995;154:1951-5.
10. Pino-Otin MR, Viñas O, de la Fuente MA et al. Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of sytemic lupus erythematosus patients. J Immunol 1995;154:3015-23.
11. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
12. Buckle AM, Hogg N. Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-γ. Eur J Immunol 1990;20:337-41.
13. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
14. Tedder TF, Penta AC, Levine HB, Freedman AS. Expression of the human leukocyte adhesion molecule, L AMI. Identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 1990;144:532-40.
15. Fawcett J, Holness CLL, Needham LA et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992;360:481-4.
16. Vazeux R, Hoffman PA, Tomita JK et al. Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature 1992;360:485-8.
17. Cordell JL, Pulford K, Turley H et al. Cellular distribution of the human leukocyte adhesion molecule ICAM-3. J Clin Pathol 1994;47:143-7.
18. Acevedo A, del Pozo MA, Arroyo AG, Sánchez-Mateos P, González-Amaro R, Sánchez-Madrid F. Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol 1993;143:774-83.
19. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584-9.
20. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989;245:1238-41.
21. MEL-14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. J Immunol 1990;144:3130-6.
22. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
23. Mason JC, Kapahi P, Haskard DO. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:519-27.
24. Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE. Increased levels of circulating intercellullar adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 1993;36:1098-102.
25. Humbría A, Díaz-González F, Campanero MR et al. Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum 1994;37:342-8.
26. de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992;175:185-90.
27. Bossy D, Buckley CD, Holness CL et al. Epitope mapping and functional properties of anti-intercellular adhesion molecule-3 (CD50) monoclonal antibodies. Eur J Immunol 1995;25:459-65.
28. Harlow E, Lane D. Labelling antibodies. In: Antibodies: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1988:348.
29. Buchan G, Barrett K, Turner M, Chantry M, Maini RN, Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 1988;73:449-55.
30. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
31. Haworth C, Brennan FM, Chantry D, Turner M, Maini RN, Feldmann M. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumour necrosis factor-α. Eur J Immunol 1991;21:2575-9.
32. Elliot MJ, Maini RN, Feldmann M et al. Randomised double-blind comparision of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
33. Kahn J, Ingraham RH, Shirley F, Migaki GI, Kishimoto TK. Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J Cell Biol 1994;125:461-70.
34. Hahne M, Lenter M, Jäger U, Vestweber D. A novel soluble form of mouse VCAM-1 is generated from a glycolipid-anchored splicing variant. Eur J Immunol 1994;24:421-8.
35. Roep BO, Heidenthal E, de Vries RRP, Kolb H, Martin S. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994;343:1590-3.
36. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517-9.